Combined metabonomic and quantitative real-time PCR analyses reveal systems metabolic changes in jurkat T-cells treated with HIV-1 tat protein

Journal of Proteome Research

Volumn 11, Issue 11, 2012, Pages 5109-5123

  Liao, Wenting ^a,b   Tan, Guangguo ^a   Zhu, Zhenyu ^a   Chen, Qiuli ^a   Lou, Ziyang ^a   Dong, Xin ^a   Zhang, Wei ^a   Pan, Wei ^a   Chai, Yifeng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

GC MS; HILIC MS; HIV 1 Tat protein; metabonomics; quantitative real time PCR; RPLC MS

Indexed keywords

ARGININE; GLYCEROPHOSPHOLIPID; GLYCINE; INOSITOL PHOSPHATE; PENTOSE PHOSPHATE; PHENYLALANINE; PROLINE; PYRUVIC ACID; SERINE; SPHINGOLIPID; THREONINE; TRANSACTIVATOR PROTEIN; TRYPTOPHAN;

AMINO ACID METABOLISM; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL GROWTH; CELL PROLIFERATION; CITRIC ACID CYCLE; FATTY ACID METABOLISM; GENE EXPRESSION; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LEUKEMIA CELL LINE; LIPID METABOLISM; MASS FRAGMENTOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY;

APOPTOSIS; CHROMATOGRAPHY, LIQUID; FLOW CYTOMETRY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; JURKAT CELLS; METABOLOMICS; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84868314430     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300173c     Document Type: Article

References (62)

1. Fauci, A. S. Host factors and the pathogenesis of HIV-induced disease Nature 1996, 384 (6609) 529-534
2. Li, J. C.; Yim, H. C.; Lau, A. S. Role of HIV-1 Tat in AIDS pathogenesis: its effects on cytokine dysregulation and contributions to the pathogenesis of opportunistic infection Aids 2010, 24 (11) 1609-1623
3. Westendorp, M. O.; Frank, R.; Ochsenbauer, C.; Stricker, K.; Dhein, J.; Walczak, H.; Debatin, K. M.; Krammer, P. H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 Nature 1995, 375 (6531) 497-500
4. Li, C. J.; Friedman, D. J.; Wang, C.; Metelev, V.; Pardee, A. B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein Science 1995, 268 (5209) 429-431
5. Secchiero, P.; Zella, D.; Capitani, S.; Gallo, R. C.; Zauli, G. Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells J. Immunol. 1999, 162 (4) 2427-2431
6. Campbell, G. R.; Loret, E. P.; Spector, S. A. HIV-1 Clade B Tat, but Not Clade C Tat, Increases X4 HIV-1 Entry into Resting but Not Activated CD4(+) T Cells J. Biol. Chem. 2010, 285 (3) 1681-1691
7. Gallo, R. C. Tat as one key to HIV-induced immune pathogenesis and Pat toroid as an important component of a vaccine Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (15) 8324-8326
8. Longo, O.; Tripiciano, A.; Fiorelli, V.; Bellino, S.; Scoglio, A.; Collacchi, B.; Alvarez, M. J.; Francavilla, V.; Arancio, A.; Paniccia, G.; Lazzarin, A.; Tambussi, G.; Din, C. T.; Visintini, R.; Narciso, P.; Antinori, A.; D'Offizi, G.; Giulianelli, M.; Carta, M.; Di Carlo, A.; Palamara, G.; Giuliani, M.; Laguardia, M. E.; Monini, P.; Magnani, M.; Ensoli, F.; Ensoli, B. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up Vaccine 2009, 27 (25-26) 3306-3312
9. Ensoli, B.; Bellino, S.; Tripiciano, A.; Longo, O.; Francavilla, V.; Marcotullio, S.; Cafaro, A.; Picconi, O.; Paniccia, G.; Scoglio, A.; Arancio, A.; Ariola, C.; Ruiz Alvarez, M. J.; Campagna, M.; Scaramuzzi, D.; Iori, C.; Esposito, R.; Mussini, C.; Ghinelli, F.; Sighinolfi, L.; Palamara, G.; Latini, A.; Angarano, G.; Ladisa, N.; Soscia, F.; Mercurio, V. S.; Lazzarin, A.; Tambussi, G.; Visintini, R.; Mazzotta, F.; Di Pietro, M.; Galli, M.; Rusconi, S.; Carosi, G.; Torti, C.; Di Perri, G.; Bonora, S.; Ensoli, F.; Garaci, E. Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART PLoS One 2010, 5 (11) e13540
10. Nazih, H.; Raffi, F.; Taieb, A.; Reynes, J.; Choutet, P.; Cassuto, J. P.; Ferry, T.; Chene, G.; Leport, C.; Bard, J. M.; Aproco-Copilote Anrs Co 08 Study Group. Peroxisome proliferator activating receptor (PPAR) alpha and gamma polymorphisms and metabolic abnormalities in HIV-infected patients receiving highly active antiretroviral therapy: The ANRS CO8 APROCO-COPILOTE Study AIDS Res. Hum. Retroviruses 2012, 28 (4) 393-399
11. Bevilacqua, M.; Dominguez, L. J.; Barbagallo, M. Insulin Resistance and the cardiometabolic syndrome in HIV infection J. CardioMetab. Syndr. 2009, 4 (1) 40-3
12. Grima, P.; Guido, M.; Chiavaroli, R.; Stano, F.; Tundo, P.; Tana, M.; de Donno, A.; Zizza, A. Altered phosphate metabolism in HIV-1-infected patients with metabolic syndrome Scand. J. Infect. Dis. 2012, 44 (2) 133-137
13. Gutierrez, A. D.; Balasubramanyam, A. Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management Endocrine 2012, 41 (1) 1-10
14. Fiehn, O. Metabolomics - the link between genotypes and phenotypes Plant Mol. Biol. 2002, 48 (1-2) 155-171
15. Munger, J.; Bennett, B. D.; Parikh, A.; Feng, X. J.; McArdle, J.; Rabitz, H. A.; Shenk, T.; Rabinowitz, J. D. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy Nat. Biotechnol. 2008, 26 (10) 1179-1186
16. Hollenbaugh, J. A.; Munger, J.; Kim, B. Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis Virology 2011, 415 (2) 153-159
17. Ruiz-Aracama, A.; Peijnenburg, A.; Kleinjans, J.; Jennen, D.; van Delft, J.; Hellfrisch, C.; Lommen, A. An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin BMC Genomics 2011, 12, 251
18. Lin, L.; Huang, Z.; Gao, Y.; Yan, X.; Xing, J.; Hang, W. LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery J. Proteome Res. 2011, 10 (3) 1396-1405
19. Wu, Z.; Li, M.; Zhao, C.; Zhou, J.; Chang, Y.; Li, X.; Gao, P.; Lu, X.; Li, Y.; Xu, G. Urinary metabonomics study in a rat model in response to protein-energy malnutrition by using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry Mol. BioSyst. 2010, 6 (11) 2157-2163
20. Liao, W.; Tan, G.; Zhu, Z.; Chen, Q.; Lou, Z.; Dong, X.; Zhang, W.; Pan, W.; Chai, Y. HIV-1 Tat induces biochemical changes in the serum of mice Virology 2012, 422 (2) 288-296
21. Ensoli, B.; Buonaguro, L.; Barillari, G.; Fiorelli, V.; Gendelman, R.; Morgan, R. A.; Wingfield, P.; Gallo, R. C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation J. Virol. 1993, 67 (1) 277-287
22. Avraham, H. K.; Jiang, S.; Lee, T. H.; Prakash, O.; Avraham, S. HIV-1 Tat-mediated effects on focal adhesion assembly and permeability in brain microvascular endothelial cells J. Immunol. 2004, 173 (10) 6228-6233
23. Perry, S. W.; Barbieri, J.; Tong, N.; Polesskaya, O.; Pudasaini, S.; Stout, A.; Lu, R.; Kiebala, M.; Maggirwar, S. B.; Gelbard, H. A. Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax J. Neurosci. 2010, 30 (42) 14153-14164
24. Chi, X.; Amet, T.; Byrd, D.; Chang, K.-H.; Shah, K.; Hu, N.; Grantham, A.; Hu, S.; Duan, J.; Tao, F.; Nicol, G.; Yu, Q. Direct effects of HIV-1 Tat on excitability and survival of primary dorsal root ganglion neurons: possible contribution to HIV-1-associated pain PLoS One 2011, 6 (9) e24412
25. Himer, L.; Csoka, B.; Selmeczy, Z.; Koscso, B.; Pocza, T.; Pacher, P.; Nemeth, Z. H.; Deitch, E. A.; Vizi, E. S.; Cronstein, B. N.; Hasko, G. Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death FASEB J. 2010, 24 (8) 2631-2640
26. Dietmair, S.; Timmins, N. E.; Gray, P. P.; Nielsen, L. K.; Kromer, J. O. Towards quantitative metabolomics of mammalian cells: development of a metabolite extraction protocol Anal. Biochem. 2010, 404 (2) 155-164
27. Sangster, T.; Major, H.; Plumb, R.; Wilson, A. J.; Wilson, I. D. A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis Analyst 2006, 131 (10) 1075-1078
28. Tan, G.; Lou, Z.; Liao, W.; Dong, X.; Zhu, Z.; Li, W.; Chai, Y. Hydrophilic interaction and reversed-phase ultraperformance liquid chromatography TOF-MS for serum metabonomic analysis of myocardial infarction in rats and its applications Mol. BioSyst. 2012, 8 (2) 548-556
29. Bijlsma, S.; Bobeldijk, I.; Verheij, E. R.; Ramaker, R.; Kochhar, S.; Macdonald, I. A.; van Ommen, B.; Smilde, A. K. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation Anal. Chem. 2006, 78 (2) 567-574
30. Smilde, A. K.; van der Werf, M. J.; Bijlsma, S.; van der Werff-van der Vat, B. J.; Jellema, R. H. Fusion of mass spectrometry-based metabolomics data Anal. Chem. 2005, 77 (20) 6729-6736
31. Yin, P.; Wan, D.; Zhao, C.; Chen, J.; Zhao, X.; Wang, W.; Lu, X.; Yang, S.; Gu, J.; Xu, G. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry Mol. BioSyst. 2009, 5 (8) 868-876
32. Storey, J. D. A direct approach to false discovery rates J. R. Statist. Soc. B 2002, 64, 479-498
33. Xia, J.; Mandal, R.; Sinelnikov, I. V.; Broadhurst, D.; Wishart, D. S. MetaboAnalyst 2.0 - a comprehensive server for metabolomic data analysis Nucleic Acids Res. 2012, 40 (W1) W127-W133
34. Xia, J.; Wishart, D. S. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst Nat. Protoc. 2011, 6 (6) 743-760
35. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001, 25 (4) 402-408
36. Campbell, G. R.; Pasquier, E.; Watkins, J.; Bourgarel-Rey, V.; Peyrot, V.; Esquieu, D.; Barbier, P.; de Mareuil, J.; Braguer, D.; Kaleebu, P.; Yirrell, D. L.; Loret, E. P. The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis J. Biol. Chem. 2004, 279 (46) 48197-48204
37. Coiras, M.; Camafeita, E.; Urena, T.; Lopez, J. A.; Caballero, F.; Fernandez, B.; Lopez-Huertas, M. R.; Perez-Olmeda, M.; Alcami, J. Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression Proteomics 2006, 6 (Suppl 1) S63-S73
38. Mahadevan, S.; Shah, S. L.; Marrie, T. J.; Slupsky, C. M. Analysis of metabolomic data using support vector machines Anal. Chem. 2008, 80 (19) 7562-7570
39. Pasikanti, K. K.; Esuvaranathan, K.; Ho, P. C.; Mahendran, R.; Kamaraj, R.; Wu, Q. H.; Chiong, E.; Chan, E. C. Y. Noninvasive Urinary Metabonomic Diagnosis of Human Bladder Cancer J. Proteome Res. 2010, 9 (6) 2988-2995
40. Wang, X.; Yang, B.; Sun, H.; Zhang, A. Pattern recognition approaches and computational systems tools for ultra performance liquid chromatography-mass spectrometry-based comprehensive metabolomic profiling and pathways analysis of biological data sets Anal. Chem. 2012, 84 (1) 428-439
41. Roe, B.; Kensicki, E.; Mohney, R.; Hall, W. W. Metabolomic profile of hepatitis C virus-infected hepatocytes PLoS One 2011, 6 (8) e23641
42. van der Werf, M. J.; Jellema, R. H.; Hankemeier, T. Microbial metabolomics: replacing trial-and-error by the unbiased selection and ranking of targets J. Ind. Microbiol. Biotechnol. 2005, 32 (6) 234-252
43. Cuperlovic-Culf, M.; Barnett, D. A.; Culf, A. S.; Chute, I. Cell culture metabolomics: applications and future directions Drug Discovery Today 2010, 15 (15-16) 610-621
44. Yopp, A. C.; Randolph, G. J.; Bromberg, J. S. Leukotrienes, sphingolipids, and leukocyte trafficking J. Immunol. 2003, 171 (1) 5-10
45. Olivera, A.; Rivera, J. Sphingolipids and the balancing of immune cell function: lessons from the mast cell J. Immunol. 2005, 174 (3) 1153-1158
46. Pavoine, C.; Pecker, F. Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology Cardiovasc. Res. 2009, 82 (2) 175-183
47. Steinbrecher, U. P.; Gomez-Munoz, A.; Duronio, V. Acid sphingomyelinase in macrophage apoptosis Curr. Opin. Lipidol. 2004, 15 (5) 531-537
48. Liang WS, M. A.; Teslovich, T. M.; de la Fuente, C; Agbottah, E; Dadgar, S; Kehn, K; Hautaniemi, S; Pumfery, A; Stephan, D. A.; Kashanchi, F. Therapeutic targets for HIV-1 infection in the host proteome Retrovirology 2005, 2 (Mar 21) 20
49. Duong, C. Q.; Bared, S. M.; Abu-Khader, A.; Buechler, C.; Schmitz, A.; Schmitz, G. Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages Biochim. Biophys. Acta 2004, 1682 (1-3) 112-119
50. Kabarowski, J. H. G2A and LPC: regulatory functions in immunity Prostaglandins Other Lipid Mediat 2009, 89 (3-4) 73-81
51. Oestvang, J.; Johansen, B. PhospholipaseA2: a key regulator of inflammatory signalling and a connector to fibrosis development in atherosclerosis Biochim. Biophys. Acta 2006, 1761 (11) 1309-1316
52. Aoki, J.; Nagai, Y.; Hosono, H.; Inoue, K.; Arai, H. Structure and function of phosphatidylserine-specific phospholipase A1 Biochim. Biophys. Acta 2002, 1582 (1-3) 26-32
53. Stewart, A.; Ghosh, M.; Spencer, D. M.; Leslie, C. C. Enzymatic properties of human cytosolic phospholipase A(2)gamma J. Biol. Chem. 2002, 277 (33) 29526-29536
54. Han, K. H.; Hong, K. H.; Ko, J.; Rhee, K. S.; Hong, M. K.; Kim, J. J.; Kim, Y. H.; Park, S. J. Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells J. Leukocyte Biol. 2004, 76 (1) 195-202
55. Kino, T.; Mirani, M.; Alesci, S.; Chrousos, G. P. AIDS-related lipodystrophy/insulin resistance syndrome Horm. Metab. Res. 2003, 35 (3) 129-136
56. Brown, T. T.; Tassiopoulos, K.; Bosch, R. J.; Shikuma, C.; McComsey, G. A. Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy Diabetes Care 2010, 33 (10) 2244-1149
57. Cifone, M. G.; Alesse, E.; Di Marzio, L.; Ruggeri, B.; Zazzeroni, F.; Moretti, S.; Famularo, G.; Steinberg, S. M.; Vullo, E.; De Simone, C. Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from AIDS patients Proc. Assoc. Am. Physicians 1997, 109 (2) 146-153
58. Moretti, S.; Alesse, E.; Di Marzio, L.; Zazzeroni, F.; Ruggeri, B.; Marcellini, S.; Famularo, G.; Steinberg, S. M.; Boschini, A.; Cifone, M. G.; De Simone, C. Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot study Blood 1998, 91 (10) 3817-3824
59. Di Marzio, L.; Alesse, E.; Roncaioli, P.; Muzi, P.; Moretti, S.; Marcellini, S.; Amicosante, G.; De Simone, C.; Cifone, M. G. Influence of L-carnitine on CD95 cross-lining-induced apoptosis and ceramide generation in human cell lines: correlation with its effects on purified acidic and neutral sphingomyelinases in vitro Proc. Assoc. Am. Physicians 1997, 109 (2) 154-163
60. Zangerle, R.; Kurz, K.; Neurauter, G.; Kitchen, M.; Sarcletti, M.; Fuchs, D. Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy Brain, Behav., Immun. 2010, 24 (3) 403-408
61. Samikkannu, T.; Rao, K. V.; Gandhi, N.; Saxena, S. K.; Nair, M. P. Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS J. Neurovirol. 2010, 16 (4) 255-263
62. Boasso, A.; Herbeuval, J. P.; Hardy, A. W.; Anderson, S. A.; Dolan, M. J.; Fuchs, D.; Shearer, G. M. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells Blood 2007, 109 (8) 3351-3359